Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Pedro R Figueroa Casas"'
Autor:
Pedro R Figueroa Casas
Publikováno v:
Revista de la Facultad de Ciencias Médicas de Córdoba, Vol 62, Iss 2 (2021)
La terapia hormonal para la mujer en menopausia ha sido revalorizada en sus indicaciones en los últimos cuatro años, a partir de estudios clínicos prospectivos que han evaluado sus beneficios y riesgos. En octubre de 2004 se efectuó un Consenso d
Externí odkaz:
https://doaj.org/article/5bbcd6678f254ea49e539bc241276b68
Autor:
Angela Hernandez, P. Barbero, B. Bellesia, Charalampos Kostopoulos, Marc Jimenez, A. Bonito Oliva, E. Viladiu, Piergiorgio Aprili, M. Cornelis, O. Malpica, M. Spagnolo, L. Poncet, E. Boter, Narcis Pellicer, A. LoBue, R. Harrison, J. Cornella, S. Heikkinen, Pedro R. Figueroa Casas, K. Libens, M. Bolla, R. Batista, G. Falcitelli, E. Barbero, G. Veredas, R. Francone, M. Damone
Publikováno v:
IEEE Transactions on Applied Superconductivity. 28:1-5
The first European superconducting winding pack (WP) and the first set of coil cases [toroidal field coil cases (TFCC)] for ITER are going to be delivered in 2017. The TFCC are steel structures that provide structural integrity to the WP, contribute
Autor:
Roberto Italo Tozzini, Gustavo Botti, C. López, Ranferi Gaona Arreola, Josue Garza Flores, Carlos Gurucharri, Enrique Lastreto, Elida Botto, Susana Bassol, Gabriela Percossi, Hildoberto Carneiro de Oliveira, Cuauhtémoc Celis-González, Gloria Penagos, Mirta Fernandez, Roger Lara Ricalde, Efrain Perez Peña, Gustavo Prieto, Martha E. Diogenes Holanda Yazlle, G. Albrecht, Gloria Alvarado, Anibal Nuñez de Pierro, Pedro R. Figueroa Casas, Jaime Silva, German Salazar, Monica G. Heredia, Oscar Contreras Ortiz, Monica Ñañez, Jorge Gomez, R. Reyes-Marquez, Jose R. Ahued, Rodrigo Cifuentes, Luz Angela Torres
Publikováno v:
Contraception. 67:367-372
This prospective, multicenter study was conducted to evaluate the contraceptive reliability, cycle control and tolerability of a 21-day oral contraceptive regimen containing 20 microg ethinylestradiol and 75 microg gestodene in four Latin American co
Publikováno v:
Menopause. 8:420-423
Objective Endometrial hyperplasia, an entity considered a precursor to endometrial carcinoma, frequently develops in women receiving unopposed estrogens. Progestins used concomitantly with estrogens can largely prevent endometrial hyperplasia and car
Autor:
Pedro R, Figueroa-Casas
Publikováno v:
Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina). 62(2 Suppl 1)
Starting from prospective clinical studies that have evaluated its benefits and risks, hormone replacement therapy in menopause women has been reassessed in its indications in the last four years. In October, 2004 a Latinamerican Experts Consensus wa
Autor:
Alejandro Oliva, Diego Turner, Pedro R. Figueroa Casas, Omar A. Arcángeli, A.R Badano, Mirkin A, Héctor Miechi, Aníbal Rodríguez, Néstor J. Aparicio
Publikováno v:
Fertility and Sterility. 31:124-129
Thirty women with secondary amenorrhea and hyperprolactinemia were studied; galactorrhea was present in 25 of them, and 18 were infertile. Serum prolactin (PRL) levels were high in all cases, between 26 and 120 ng/ml. All women were treated with brom
Publikováno v:
Maturitas. 8:335-344
In this study, the histological definition of endometrial cancer precursor (ECP) lesions is discussed and a comparison is made of clinical and histological parameters of ECP patients and endometrial cancer (EC) patients. ECP lesions were divided in 3
Autor:
Isaac Schlaen, Pedro R. Figueroa-Casas
Publikováno v:
Maturitas. 9(4)
Seventy-four symptomatic postmenopausal women received conjugated equine estrogens, 0.625 mg daily, alternating 3 wk of treatment with 1 wk free. Medroxyprogesterone acetate, 10 mg daily, was added from day 12 to day 21 of the estrogen therapy. The l
Autor:
Néstor J. Aparicio, A.R Badano, Carlos Biccoca, Ricardo R. Berli, Héctor Badano, Andrew V. Schally, Pedro R. Figueroa Casas, Leo J. Lencioni
Publikováno v:
Fertility and sterility. 26(6)
Fifteen infertile, anovulatory women, ages 20 to 37, were treated with synthetic luteinizing hormone-releasing hormone (LH-RH) to stimulate follicular maturation and/or ovulation. Thirteen of the patients had been treated unsuccessfully with other th